{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T11:44:25Z","timestamp":1785930265137,"version":"3.56.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY006594"],"award-info":[{"award-number":["EY006594"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.oret.2018.11.013","type":"journal-article","created":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T22:53:42Z","timestamp":1544136822000},"page":"305-315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Fellow Eye Status Is a Biomarker for the Progression Rate of Geographic Atrophy"],"prefix":"10.1016","volume":"3","author":[{"given":"Liangbo L.","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feimei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5563-6848","authenticated-orcid":false,"given":"Holly K.","family":"Grossetta Nardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucian V.","family":"Del Priore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2018.11.013_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archopht.1975.01010020023003","article-title":"Geographic atrophy of the retinal pigment epithelium: a manifestation of senile macular degeneration","volume":"93","author":"Blair","year":"1975","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2018.11.013_bib2","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/archopht.122.4.564","article-title":"Prevalence of age-related macular degeneration in the United States","volume":"122","author":"Friedman","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2018.11.013_bib3","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.oret.2018.11.013_bib4","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1001\/archophthalmol.2009.198","article-title":"Change in area of geographic atrophy in the age-related eye disease study: AREDS report number 26","volume":"127","author":"Lindblad","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2018.11.013_bib5","first-page":"25","article-title":"The natural history of geographic atrophy, the advanced atrophic form of age-related macular degeneration","volume":"5","author":"Sunness","year":"1999","journal-title":"Mol Vis"},{"key":"10.1016\/j.oret.2018.11.013_bib6","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ophtha.2006.09.016","article-title":"The long-term natural history of geographic atrophy from age-related macular degeneration: enlargement of atrophy and implications for interventional clinical trials","volume":"114","author":"Sunness","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2018.11.013_bib7","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.ajo.2008.05.050","article-title":"The epidemiology of progression of pure geographic atrophy: the Beaver Dam Eye Study","volume":"146","author":"Klein","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2018.11.013_bib8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000361077","article-title":"Geographic atrophy progression in eyes with age-related macular degeneration: role of fundus autofluorescence patterns, fellow eye and baseline atrophy area","volume":"52","author":"Bat\u0131o\u011flu","year":"2014","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.oret.2018.11.013_bib9","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ophtha.2015.09.036","article-title":"Natural history of geographic atrophy progression secondary to age-related macular degeneration (Geographic Atrophy Progression Study)","volume":"123","author":"Schmitz-Valckenberg","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2018.11.013_bib10","doi-asserted-by":"crossref","first-page":"6552","DOI":"10.1167\/iovs.11-7298","article-title":"Progression of age-related geographic atrophy: role of the\u00a0fellow eye","volume":"52","author":"Fleckenstein","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2018.11.013_bib11","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1136\/bjophthalmol-2014-306338","article-title":"Progressing geographic atrophy: choroidal thickness and retinal sensitivity identify two clinical phenotypes","volume":"99","author":"Pilotto","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2018.11.013_bib12","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.oret.2018.01.019","article-title":"Natural history of geographic atrophy in untreated eyes with nonexudative age-related macular degeneration: a systematic review and meta-analysis","volume":"2","author":"Shen","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2018.11.013_bib13","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.oret.2018.11.013_bib14","series-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"Wells","year":"2011"},{"key":"10.1016\/j.oret.2018.11.013_bib15","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1001\/jamapsychiatry.2015.2313","article-title":"Prognosis of brief psychotic episodes: a meta-analysis","volume":"73","author":"Fusar-Poli","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.oret.2018.11.013_bib16","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1167\/iovs.15-18595","article-title":"The effect of statins on intraocular pressure and on the incidence and progression of glaucoma: a systematic review and meta-analysis statins and IOP, glaucoma incidence and progression","volume":"57","author":"McCann","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2018.11.013_bib17","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ophtha.2010.08.018","article-title":"Progression of geographic atrophy in age-related macular degeneration imaged with spectral domain optical coherence tomography","volume":"118","author":"Yehoshua","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2018.11.013_bib18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1001\/jamaophthalmol.2013.572","article-title":"Square root transformation of geographic atrophy area measurements to eliminate dependence of growth rates on baseline lesion measurements: a reanalysis of age-related eye disease study report no. 26","volume":"131","author":"Feuer","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2018.11.013_bib19","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ophtha.2014.11.007","article-title":"Growth of geographic atrophy in the comparison of age-related macular degeneration treatments trials","volume":"122","author":"Grunwald","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2018.11.013_bib20","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/jamaophthalmol.2013.818","article-title":"Progression of lesion size in untreated eyes with exudative age-related macular degeneration: a meta-analysis using Lineweaver-Burk plots","volume":"131","author":"Liu","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2018.11.013_bib21","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.ophtha.2009.03.055","article-title":"Natural history of predominantly classic, minimally classic, and occult subgroups in exudative\u00a0age-related macular degeneration","volume":"116","author":"Shah","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2018.11.013_bib22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ajo.2006.09.043","article-title":"Progressive visual loss in subfoveal exudation in age-related macular degeneration: a meta-analysis using Lineweaver-Burke plots","volume":"143","author":"Shah","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2018.11.013_bib23","unstructured":"Shen L, Liu F, Grossetta Nardini H, Del Priore LV. Reclassification of fundus autofluorescence patterns surrounding geographic atrophy based on progression rate: a systematic review and meta-analysis. Retina. In press."},{"key":"10.1016\/j.oret.2018.11.013_bib24","first-page":"236","article-title":"Another cautionary note about R 2: Its use in weighted least-squares regression analysis","volume":"42","author":"Willett","year":"1988","journal-title":"Am Stat"},{"key":"10.1016\/j.oret.2018.11.013_bib25","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1037\/1082-989X.11.2.193","article-title":"Assessing heterogeneity in meta-analysis: Q statistic or I2 index?","volume":"11","author":"Huedo-Medina","year":"2006","journal-title":"Psychol Methods"},{"key":"10.1016\/j.oret.2018.11.013_bib26","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics Med"},{"key":"10.1016\/j.oret.2018.11.013_bib27","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/jamaophthalmol.2018.1544","article-title":"Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: Chroma and Spectri phase 3 randomized clinical trials","volume":"136","author":"Holz","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2018.11.013_bib28","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.ophtha.2018.05.028","article-title":"Progression of geographic atrophy in age-related macular degeneration: AREDS2 report number 16","volume":"125","author":"Keenan","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2018.11.013_bib29","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00417-010-1483-x","article-title":"The symmetry of phenotype between eyes of patients with early\u00a0and late bilateral age-related macular degeneration (AMD)","volume":"249","author":"Mann","year":"2011","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2018.11.013_bib30","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1167\/iovs.09-3547","article-title":"Concordance of disease progression in bilateral geographic atrophy due to AMD","volume":"51","author":"Fleckenstein","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2018.11.013_bib31","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ophtha.2017.08.038","article-title":"The progression of geographic atrophy secondary to age-related macular degeneration","volume":"125","author":"Fleckenstein","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2018.11.013_bib32","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000443209","article-title":"Geographic atrophy and choroidal neovascularization in the same eye: a review","volume":"55","author":"Kaszubski","year":"2016","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.oret.2018.11.013_bib33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ophtha.2016.09.012","article-title":"Incidence and growth of geographic atrophy during 5 years of comparison of age-related macular degeneration treatments trials","volume":"124","author":"Grunwald","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2018.11.013_bib34","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0140-6736(13)61501-9","article-title":"Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial","volume":"382","author":"Chakravarthy","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.oret.2018.11.013_bib35","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/j.ophtha.2016.07.007","article-title":"Ranibizumab treatment for pigment epithelial detachment secondary to neovascular age-related macular degeneration: post hoc analysis of the HARBOR study","volume":"123","author":"Sarraf","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2018.11.013_bib36","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ajo.2014.10.035","article-title":"Risk factors for geographic atrophy after intravitreal ranibizumab injections for retinal angiomatous proliferation","volume":"159","author":"Cho","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2018.11.013_bib37","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ophtha.2017.08.030","article-title":"Natural history of subclinical neovascularization in nonexudative age-related macular degeneration using swept-source OCT angiography","volume":"125","author":"de Oliveira Dias","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2018.11.013_bib38","first-page":"2224","article-title":"Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study report number 3","volume":"107","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2018.11.013_bib39","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.ophtha.2003.11.010","article-title":"Risk factors for incident age-related macular degeneration: pooled findings from 3 continents","volume":"111","author":"Tomany","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2018.11.013_bib40","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.ophtha.2008.03.008","article-title":"Risk factors for choroidal neovascularization and geographic atrophy in the complications of age-related macular degeneration prevention trial","volume":"115","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2018.11.013_bib41","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ophtha.2004.10.047","article-title":"Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS). AREDS report no. 19","volume":"112","author":"Clemons","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2018.11.013_bib42","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ajo.2003.11.069","article-title":"The epidemiology of age-related macular degeneration","volume":"137","author":"Klein","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2018.11.013_bib43","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000100046","article-title":"The LOC387715 gene, smoking, body mass index, environmental associations with advanced age-related macular degeneration","volume":"63","author":"Francis","year":"2007","journal-title":"Hum Hered"},{"key":"10.1016\/j.oret.2018.11.013_bib44","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1167\/iovs.05-1143","article-title":"Complement factor H variant Y402H is a major risk determinant for geographic atrophy and choroidal neovascularization in smokers and nonsmokers","volume":"47","author":"Sepp","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2018.11.013_bib45","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1126\/science.1109557","article-title":"Complement factor H polymorphism in age-related macular degeneration","volume":"308","author":"Klein","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.oret.2018.11.013_bib46","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1097\/IAE.0b013e318240a540","article-title":"The ARMS2 A69S variant and bilateral advanced age-related macular degeneration","volume":"32","author":"Schwartz","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.oret.2018.11.013_bib47","first-page":"1395","article-title":"Joint effects of polymorphisms in the HTRA1, LOC387715\/ARMS2, and CFH genes on AMD in a Caucasian population","volume":"14","author":"Francis","year":"2008","journal-title":"Mol Vis"},{"key":"10.1016\/j.oret.2018.11.013_bib48","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0161-6420(89)32694-7","article-title":"Atrophic macular degeneration. Rate of spread of geographic atrophy and visual loss","volume":"96","author":"Schatz","year":"1989","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2018.11.013_bib49","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1001\/archopht.1993.01090090041018","article-title":"Five-year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization","volume":"111","author":"Group","year":"1993","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2018.11.013_bib50","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1001\/archopht.1997.01100150743009","article-title":"Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration","volume":"115","author":"Maguire","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2018.11.013_bib51","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/S0161-6420(99)00509-6","article-title":"The development of choroidal neovascularization in eyes with the geographic atrophy form of age-related macular degeneration","volume":"106","author":"Sunness","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2018.11.013_bib52","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1016\/j.neurobiolaging.2014.05.003","article-title":"Choriocapillaris breakdown precedes retinal degeneration in age-related macular degeneration","volume":"35","author":"Biesemeier","year":"2014","journal-title":"Neurobiol Aging"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653018304275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653018304275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:25:19Z","timestamp":1762853119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653018304275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S2468653018304275"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2018.11.013","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fellow Eye Status Is a Biomarker for the Progression Rate of Geographic Atrophy","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2018.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}